1. A single‐dose euglycaemic clamp study in two cohorts to compare the exposure of SAR341402 (insulin aspart) Mix 70/30 with US‐ and European‐approved versions of insulin aspart Mix 70/30 and SAR341402 rapid‐acting solution in subjects with type 1 diabetes. Issue 3 (10th December 2020) Authors: Kapitza, Christoph; Nosek, Leszek; Schmider, Wolfgang; Teichert, Lenore; Mukherjee, Bhaswati; Nowotny, Irene Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 3(2021) Page Start: 674 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine. (August 2015) Authors: Heise, Tim; Hövelmann, Ulrike; Nosek, Leszek; Hermanski, Lidia; Bøttcher, Susanne G; Haahr, Hanne Journal: Expert opinion on drug metabolism and toxicology Issue: Volume 11:Number 8(2015:Aug.) Page Start: 1193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Euglycaemic glucose clamp: what it can and cannot do, and how to do it. Issue 10 (13th July 2016) Authors: Heise, Tim; Zijlstra, Eric; Nosek, Leszek; Heckermann, Sascha; Plum‐Mörschel, Leona; Forst, Thomas Journal: Diabetes, obesity & metabolism Issue: Volume 18:Issue 10(2016) Page Start: 962 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Insulin degludec: Lower day‐to‐day and within‐day variability in pharmacodynamic response compared with insulin glargine 300 U/mL in type 1 diabetes. Issue 7 (23rd April 2017) Authors: Heise, Tim; Nørskov, Marianne; Nosek, Leszek; Kaplan, Kadriye; Famulla, Susanne; Haahr, Hanne L. Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 7(2017) Page Start: 1032 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes. (January 2018) Authors: Zijlstra, Eric; Demissie, Marek; Graungaard, Tina; Heise, Tim; Nosek, Leszek; Bode, Bruce Journal: Journal of diabetes science and technology Issue: Volume 12:Number 1(2018:Jan.) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. New Clamp-PID Algorithm for Automated Glucose Clamps Improves Clamp Quality. (March 2022) Authors: Benesch, Carsten; Kuhlenkötter, Mareike; Nosek, Leszek; Heise, Tim Journal: Journal of diabetes science and technology Issue: Volume 16:Number 2(2022) Page Start: 408 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacological properties of faster‐acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double‐blind, crossover trial. Issue 2 (14th November 2016) Authors: Heise, Tim; Zijlstra, Eric; Nosek, Leszek; Rikte, Tord; Haahr, Hanne Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 2(2017) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Semaglutide, a once‐weekly human GLP‐1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel. (14th January 2015) Authors: Kapitza, Christoph; Nosek, Leszek; Jensen, Lene; Hartvig, Helle; Jensen, Christine B.; Flint, Anne Journal: Journal of clinical pharmacology Issue: Volume 55:Number 5(2015:May) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Similar pharmacokinetics and pharmacodynamics of rapid‐acting insulin lispro products SAR342434 and US‐ and EU‐approved Humalog in subjects with type 1 diabetes. Issue 5 (9th February 2017) Authors: Kapitza, Christoph; Nowotny, Irene; Lehmann, Anne; Bergmann, Karin; Rotthaeuser, Baerbel; Nosek, Leszek; Becker, Reinhard H. A. Journal: Diabetes, obesity & metabolism Issue: Volume 19:Issue 5(2017) Page Start: 622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Steady state is reached within 2–3 days of once‐daily administration of degludec, a basal insulin with an ultralong duration of action1. (24th March 2015) Authors: Heise, Tim; Korsatko, Stefan; Nosek, Leszek; Coester, Hans Veit; Deller, Sigrid; Roepstorff, Carsten; Segel, Stine; Kapur, Rahul; Haahr, Hanne; Hompesch, Marcus Journal: Journal of diabetes Issue: Volume 8:Number 1(2016:Jan.) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗